A general practice delivered, technology supported, lifestyle program for Type 2 Diabetes (T2D) management – Evaluation Study (GP-T2D)

Not Applicable

• Conditions: Type 2 Diabetes; Glycaemic Control; Overweight/Obesity; Diet and Nutrition - Obesity; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12622000635763
• Lead Sponsor: Commonwealth Scientific and Industrial Research Organisation (CSIRO)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-29
• Last Update Posted: 9 May 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

•18 to 75 years of age,
• BMI of > 27kg/m2
• identified as suitable as per clinical management needs, by their treating GP
• medically diagnosed as having type 2 diabetes
• willing to participate and engage with the lifestyle strategy prescribed
• able to read, speak and understand written English (resources will be presented in English
only)
• willing to wear and self-manage a real-time continuous glucose monitoring device and
sensor, including sensor insertion and removal
• willing to be monitored by the clinical research team
• Access to a smart phone

Exclusion Criteria

• Have pre-existing Oncological issues
• HbA1 >15%
• diagnosed as having type 1 Diabetes
• pregnant or lactating women
• currently undergoing bariatric surgery or within the first 2 years of a bariatric surgery procedure
. Not willing to wear the CGM device
. Not willing to attend GP clinic for clinical appointments

Study & Design

• Study Type: Interventional
• Study Design: Not specified